PROTEIN INHIBITOR OR DEGRADING AGENT, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PHARMACEUTICAL USE

A protein inhibitor or degrading agent, a pharmaceutical composition comprising same and a pharmaceutical use. Provided are a compound represented by general formula (I), and a pharmaceutical composition containing same. Also disclosed are an application of the compound of the general formula as a protein inhibitor and/or a protein degrading agent and a pharmaceutical use. PIN—Linker—E (I).

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 08. Feb. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

YE GUOZHONG [VerfasserIn]
DU YONG [VerfasserIn]
ZHANG YUHUA GEORGE [VerfasserIn]
CHEN JINJU [VerfasserIn]
CHEN SHAOJUN [VerfasserIn]
LIU ZHI [VerfasserIn]
CHEN YONGFENG [VerfasserIn]
ZHAO CUNLIANG [VerfasserIn]
LIU YAO [VerfasserIn]
FANG TAO [VerfasserIn]
YU MIAO [VerfasserIn]
LU XIAORONG [VerfasserIn]
WANG YUXIA [VerfasserIn]
WANG ZHAOFU [VerfasserIn]
WU QIANG [VerfasserIn]
KONG DESHENG [VerfasserIn]
ZHANG LI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
C07F: Acyclic, carbocyclic, or heterocyclic compounds con (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-02-08, Last update posted on www.tib.eu: 2024-02-23, Last updated: 2024-03-01

Patentnummer:

AU2022297504

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA019263562